Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ruffy Guilatco"'
Autor:
Stavros Patsialas, Heather Fowler, Ruffy Guilatco, Stephanie Salts, Feng Richard Xia, Sonja Gomez Perez, Andreas Iwanowitsch, Matthias Kohnle
Publikováno v:
Clinical Nephrology. 99:247-255
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::830d1d7bcb5328e395dca08fe78f7c35
https://doi.org/10.5414/cn110825
https://doi.org/10.5414/cn110825
Autor:
Robin Christensen, Peter C. Taylor, Ruffy Guilatco, Heather Fowler, Boulos Haraoui, Pamela Selema, K. F. Liau, Shahrzad Moosavi, Markus Mueller
Publikováno v:
Rheumatology Advances in Practice
Taylor, P C, Christensen, R, Moosavi, S, Selema, P, Guilatco, R, Fowler, H, Mueller, M, Liau, K F & Haraoui, B 2021, ' Real-life drug persistence in patients with rheumatic diseases treated with CT-P13 : a prospective observational cohort study (PERSIST) ', Rheumatology advances in practice, vol. 5, no. 2, rkab026 . https://doi.org/10.1093/rap/rkab026
Taylor, P C, Christensen, R, Moosavi, S, Selema, P, Guilatco, R, Fowler, H, Mueller, M, Liau, K F & Haraoui, B 2021, ' Real-life drug persistence in patients with rheumatic diseases treated with CT-P13 : a prospective observational cohort study (PERSIST) ', Rheumatology advances in practice, vol. 5, no. 2, rkab026 . https://doi.org/10.1093/rap/rkab026
ObjectiveThe aim was to report results from PERSIST, a real-life, observational, prospective cohort study of CT-P13, an infliximab (IFX) biosimilar, for treatment of patients with RA, AS or PsA who were biologic naïve or switched from an IFX referen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6652949750b80b83ae092dd45d69421
https://pubmed.ncbi.nlm.nih.gov/34377890
https://pubmed.ncbi.nlm.nih.gov/34377890
Publikováno v:
American Journal of Nephrology. 48:214-224
Background: For patients with anemia undergoing hemodialysis, erythropoiesis-stimulating agents (ESAs) are typically dosed via precise algorithms. Using one such algorithm, we assessed the maintenance of hemoglobin levels in patients switched from ep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b0d766d8d4c21480fcc986ba89cccf0
https://doi.org/10.1159/000492621
https://doi.org/10.1159/000492621
Autor:
Shahrzad Moosavi, Boulos Haraoui, Heather Fowler, Peter C. Taylor, Claire Bombardier, Ruffy Guilatco, Pamela Selema, Robin Christensen
Publikováno v:
Poster Presentations.
Background CT-P13, an infliximab biosimilar, has been available in Europe and Canada since 2015, and real-world experience with CT-P13 is important to support the safety of this medication. PERSIST is an ongoing, observational cohort study evaluating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edaf3a8652d6598084820c198889bb74
https://doi.org/10.1136/annrheumdis-2019-eular.2655
https://doi.org/10.1136/annrheumdis-2019-eular.2655
Autor:
Julia Ershova, Ma Tarcela Gler, John L. Johnson, Janice C. Caoili, Ruffy Guilatco, Peter Cegielski
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 89:943-949
Alternatives to culture are needed in high burden countries to assess whether response to treatment of multidrug-resistant-tuberculosis (MDR-TB) is satisfactory. The objective was to assess the association of weight gain and treatment outcome. The me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982d03226cc1d6261235eac2cf617a8c
https://doi.org/10.4269/ajtmh.13-0011
https://doi.org/10.4269/ajtmh.13-0011